Saudi Arabia, unit by unit.
In Saudi Arabia, the SFDA's Drug Track and Trace System (RSD) tracks every unit of registered human medicine by a GTIN and serial number in a GS1 DataMatrix, with a GLN for every site in the supply chain.
Saudi Arabia tracks every unit of registered human medicine through the SFDA's Drug Track and Trace System, known as RSD. Each pack carries a GS1 DataMatrix with its GTIN, serial number, expiry date and batch number, and every site in the chain is identified by a GS1 Global Location Number. The system records each transaction from production or import to consumption, so manufacturers, warehouses, pharmacies and hospitals all report into it.
Saudi Arabia, in three facts.
Saudi Arabia · SFDA Drug Track and Trace System (RSD) · GS1 DataMatrix with GTIN, serial, expiry and batch · a GLN for every stakeholder.
Saudi Arabia's Drug Track and Trace System tracks each unit of registered human medicine, identifying each location by a GLN and each pack by a GTIN and serial number in a GS1 DataMatrix, from production or import to consumption.
Source: SFDA, RSD stakeholder management portal manualEvery drug unit tracked in Saudi Arabia carries a GS1 DataMatrix holding the GTIN (01), serial number (21), expiry date (17) and batch number (10).
Source: SFDA, Integration Guide for the Drug Track & Trace System, version 2.0Every stakeholder in Saudi Arabia's drug track and trace system needs its own GLN, after which the SFDA registers it in the system.
Source: SFDA, Integration Guide for the Drug Track & Trace System, version 2.0
Every unit, every move.
A DataMatrix on every unit
Each tracked unit carries a GS1 DataMatrix holding the GTIN (01), serial number (21), expiry date (17) and batch number (10), with the same data printed for people to read.
A GLN for every site
Every stakeholder, from manufacturer and warehouse to hospital and pharmacy, needs its own GS1 Global Location Number before the SFDA registers it in the system.
Every move is reported
The system follows each unit from production or importation to consumption, so the SFDA can see where a recalled or blocked product is.
Bulk moves through PTS
Aggregated shipments are passed between trading partners through the SFDA's Package Transfer Service, so a case or pallet carries the record of what is inside it.
The timeline, as it stands.
These requirements are in force for medicines sold in Saudi Arabia. The SFDA revises its barcode specifications and integration guide from time to time, so check its current documents before each artwork change.
Three moves that de-risk the deadline.
Get your GS1 identifiers first
GTINs for every pack and GLNs for every site come before any system work.
Plan the integration window
Connections are tested on the SFDA's test environment before production. Build that time into the launch plan.
Design once for the EU too
A plant that also supplies the EU may face the EU FMD, CBAM or the battery passport. Design the product data once and serve both markets from it.
One identity, Riyadh to Rotterdam.
Aeroz works alongside RSD, not in place of it. A tag on the pack or case gives distributors and hospitals a tap check that a copied barcode cannot pass, and keeps the custody record that a recall or an SFDA query needs.
Saudi Arabia, answered.
What is RSD in Saudi Arabia?
RSD is the SFDA's Drug Track and Trace System (DTTS). It tracks each unit of registered human medicine distributed in Saudi Arabia, using a GTIN and serial number in a GS1 DataMatrix and a GLN for each location.
What must the Saudi DataMatrix contain?
The GTIN, serial number, expiry date and batch number, encoded with GS1 Application Identifiers (01), (21), (17) and (10).
Who reports to the system?
Every stakeholder in the chain: manufacturers, importers, warehouses, hospitals and pharmacies, each registered with its own GLN.
Does Aeroz replace RSD reporting?
No. RSD reporting stays with your track-and-trace system. Aeroz adds a physical identity and a custody record on top of it.
Know exactly where you stand, in 14 days.
A fixed-fee Aeroz audit maps your products against Saudi drug track-and-trace (RSD) requirements and EU export rules and returns a written readiness assessment, a data-mapping review, and a scoped pilot plan with cost and timeline.